JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
491 * ! | Wed, 8/1/2012, 10:30 AM - 12:20 PM | CC-Room 25C | |
Challenges in Biomarker and Surrogate Endpoint Qualification — Topic Contributed Papers | |||
Biopharmaceutical Section , International Indian Statistical Association | |||
Organizer(s): Qunming Dong, Vertex Pharmaceuticals | |||
Chair(s): Qunming Dong, Vertex Pharmaceuticals | |||
10:35 AM | Statistical Evaluation of Surrogate Endpoints: Validity, Efficiency, and Sensitivity — Pandurang Kulkarni, Eli Lilly and Company ; Yongming Qu, Eli Lilly and Company ; Wen Li, Singapore Clinical Research Institute | ||
10:55 AM | Biomarker Qualification: FDA Experience — Aloka Chakravarty, FDA/CDER | ||
11:15 AM | Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials — Ying Huang, Fred Hutchinson Cancer Research Center ; Peter B Gilbert, University of Washington/Fred Hutchinson Cancer Research Center | ||
11:35 AM | Related Causal Frameworks for Surrogate Outcomes in Randomized Trials, with Extensions to Observational Studies and Beyond — Marshall Joffe, University of Pennsylvania | ||
12:15 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.